The validated classification criteria for systemic sclerosis (scleroderma). Weighted scoring across skin thickening, fingertip lesions, telangiectasia, nailfold capillary abnormalities, SSc-related antibodies, pulmonary involvement, and Raynaud's phenomenon. A score of 9 or more classifies SSc. Sensitivity 91%, specificity 92%.
| Score | Classification | Notes |
|---|---|---|
| < 9 | Does Not Classify as SSc | Insufficient score. Consider early/incomplete SSc or alternative diagnosis. |
| >=9 | Classifies as Systemic Sclerosis | Sensitivity 91%, specificity 92% in the validation dataset. |
The maximum score is 19 (9 + 3 + 2 + 2 + 3 + 2 + 3 = 24 if all items present simultaneously, but skin thickening proximal to MCPs alone reaches threshold). These criteria do not apply to patients with SSc-like disorders not explained by SSc (e.g., nephrogenic systemic fibrosis, scleroderma-like GVHD, diabetic cheiroarthropathy, eosinophilic fasciitis).
The 2013 ACR/EULAR criteria were developed by van den Hoogen, Khanna, Fransen, Johnson, and colleagues, published simultaneously in Arthritis and Rheumatism and Annals of the Rheumatic Diseases in 2013. They replaced the 1980 ACR criteria that had high specificity but poor sensitivity for early and limited SSc. The new criteria were validated in 1656 SSc cases and 1883 controls, achieving sensitivity 91% and specificity 92%.